Legal & General Group PLC Surface Oncology, Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$1.42 - $3.15 $7,680 - $17,038	-5,409 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$6.45 - $9.09 $34,888 - $49,167	5,409 New	5,409 $41,000
Q3 2019 Nov 13, 2019	SELL	$1.4 - $2.84 $2,772 - $5,623	-1,980 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.11 - $5.88 $3,703 - $5,297	901 Added 83.5%	1,980 $9,000
Q2 2018 Aug 10, 2018	BUY	$12.83 - $17.41 $13,843 - $18,785	1,079 New	1,079 $18,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.